Cargando…

A Customized Microfluidic Paper-Based Platform for Colorimetric Immunosensing: Demonstrated via hCG Assay for Pregnancy Test

Over the past decades, paper-based lateral flow immunoassays (LFIAs) have been extensively developed for rapid, facile, and low-cost detection of a wide array of target analytes in a point-of-care manner. Conventional home pregnancy tests are the most significant example of LFAs, which detect elevat...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahbar, Mohammad, Zou, Siyi, Baharfar, Mahroo, Liu, Guozhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699738/
https://www.ncbi.nlm.nih.gov/pubmed/34940231
http://dx.doi.org/10.3390/bios11120474
_version_ 1784620586003070976
author Rahbar, Mohammad
Zou, Siyi
Baharfar, Mahroo
Liu, Guozhen
author_facet Rahbar, Mohammad
Zou, Siyi
Baharfar, Mahroo
Liu, Guozhen
author_sort Rahbar, Mohammad
collection PubMed
description Over the past decades, paper-based lateral flow immunoassays (LFIAs) have been extensively developed for rapid, facile, and low-cost detection of a wide array of target analytes in a point-of-care manner. Conventional home pregnancy tests are the most significant example of LFAs, which detect elevated concentrations of human chorionic gonadotrophin (hCG) in body fluids to identify early pregnancy. In this work, we have upgraded these platforms to a higher version by developing a customized microfluidic paper-based analytical device (μPAD), as the new generation of paper-based point-of-care platforms, for colorimetric immunosensing. This will offer a cost-efficient and environmentally friendly alternative platform for paper-based immunosensing, eliminating the need for nitrocellulose (NC) membrane as the substrate material. The performance of the developed platform is demonstrated by detection of hCG (as a model case) in urine samples and subsequently indicating positive or negative pregnancy. A dual-functional silane-based composite was used to treat filter paper in order to enhance the colorimetric signal intensity in the detection zones of μPADs. In addition, microfluidic pathways were designed in a manner to provide the desired regulated fluid flow, generating sufficient incubation time (delays) at the designated detection zones, and consequently enhancing the obtained signal intensity. The presented approaches allow to overcome the existing limitations of μPADs in immunosensing and will broaden their applicability to a wider range of assays. Although, the application of the developed hCG μPAD assay is mainly in qualitative (i.e., positive or negative) detection of pregnancy, the semi-quantitative measurement of hCG was also investigated, indicating the viability of this assay for sensitive detection of the target hCG analyte within the related physiological range (i.e., 10–500 ng/mL) with a LOD value down to 10 ng/mL.
format Online
Article
Text
id pubmed-8699738
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86997382021-12-24 A Customized Microfluidic Paper-Based Platform for Colorimetric Immunosensing: Demonstrated via hCG Assay for Pregnancy Test Rahbar, Mohammad Zou, Siyi Baharfar, Mahroo Liu, Guozhen Biosensors (Basel) Article Over the past decades, paper-based lateral flow immunoassays (LFIAs) have been extensively developed for rapid, facile, and low-cost detection of a wide array of target analytes in a point-of-care manner. Conventional home pregnancy tests are the most significant example of LFAs, which detect elevated concentrations of human chorionic gonadotrophin (hCG) in body fluids to identify early pregnancy. In this work, we have upgraded these platforms to a higher version by developing a customized microfluidic paper-based analytical device (μPAD), as the new generation of paper-based point-of-care platforms, for colorimetric immunosensing. This will offer a cost-efficient and environmentally friendly alternative platform for paper-based immunosensing, eliminating the need for nitrocellulose (NC) membrane as the substrate material. The performance of the developed platform is demonstrated by detection of hCG (as a model case) in urine samples and subsequently indicating positive or negative pregnancy. A dual-functional silane-based composite was used to treat filter paper in order to enhance the colorimetric signal intensity in the detection zones of μPADs. In addition, microfluidic pathways were designed in a manner to provide the desired regulated fluid flow, generating sufficient incubation time (delays) at the designated detection zones, and consequently enhancing the obtained signal intensity. The presented approaches allow to overcome the existing limitations of μPADs in immunosensing and will broaden their applicability to a wider range of assays. Although, the application of the developed hCG μPAD assay is mainly in qualitative (i.e., positive or negative) detection of pregnancy, the semi-quantitative measurement of hCG was also investigated, indicating the viability of this assay for sensitive detection of the target hCG analyte within the related physiological range (i.e., 10–500 ng/mL) with a LOD value down to 10 ng/mL. MDPI 2021-11-25 /pmc/articles/PMC8699738/ /pubmed/34940231 http://dx.doi.org/10.3390/bios11120474 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Rahbar, Mohammad
Zou, Siyi
Baharfar, Mahroo
Liu, Guozhen
A Customized Microfluidic Paper-Based Platform for Colorimetric Immunosensing: Demonstrated via hCG Assay for Pregnancy Test
title A Customized Microfluidic Paper-Based Platform for Colorimetric Immunosensing: Demonstrated via hCG Assay for Pregnancy Test
title_full A Customized Microfluidic Paper-Based Platform for Colorimetric Immunosensing: Demonstrated via hCG Assay for Pregnancy Test
title_fullStr A Customized Microfluidic Paper-Based Platform for Colorimetric Immunosensing: Demonstrated via hCG Assay for Pregnancy Test
title_full_unstemmed A Customized Microfluidic Paper-Based Platform for Colorimetric Immunosensing: Demonstrated via hCG Assay for Pregnancy Test
title_short A Customized Microfluidic Paper-Based Platform for Colorimetric Immunosensing: Demonstrated via hCG Assay for Pregnancy Test
title_sort customized microfluidic paper-based platform for colorimetric immunosensing: demonstrated via hcg assay for pregnancy test
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699738/
https://www.ncbi.nlm.nih.gov/pubmed/34940231
http://dx.doi.org/10.3390/bios11120474
work_keys_str_mv AT rahbarmohammad acustomizedmicrofluidicpaperbasedplatformforcolorimetricimmunosensingdemonstratedviahcgassayforpregnancytest
AT zousiyi acustomizedmicrofluidicpaperbasedplatformforcolorimetricimmunosensingdemonstratedviahcgassayforpregnancytest
AT baharfarmahroo acustomizedmicrofluidicpaperbasedplatformforcolorimetricimmunosensingdemonstratedviahcgassayforpregnancytest
AT liuguozhen acustomizedmicrofluidicpaperbasedplatformforcolorimetricimmunosensingdemonstratedviahcgassayforpregnancytest
AT rahbarmohammad customizedmicrofluidicpaperbasedplatformforcolorimetricimmunosensingdemonstratedviahcgassayforpregnancytest
AT zousiyi customizedmicrofluidicpaperbasedplatformforcolorimetricimmunosensingdemonstratedviahcgassayforpregnancytest
AT baharfarmahroo customizedmicrofluidicpaperbasedplatformforcolorimetricimmunosensingdemonstratedviahcgassayforpregnancytest
AT liuguozhen customizedmicrofluidicpaperbasedplatformforcolorimetricimmunosensingdemonstratedviahcgassayforpregnancytest